Latest Blogs

May 25, 2018
Dr. Jane Lowe Meisel shares a first look at the program for the Women's Networking Center at the 2018 ASCO Annual Meeting. 
May 25, 2018
Dr. Edward S. Kim encourages you to register today and join the Research Community Forum in September for 2 days of learning and collaboration.
May 24, 2018
In the midst of troubles in North Africa and Middle East, we keep up with oncology education and research and keep up hope for the betterment of patient care and advancement of science in Arab countries. 
May 24, 2018
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
Subscribe to this column

Gilberto Lopes, MD, MBA

Gilberto de Lima Lopes Jr., MD, MBA, FAMS, a medical oncologist, is medical director for international programs and associate director for global oncology at the Sylvester Comprehensive Cancer Center and associate professor of clinical medicine at the University of Miami in Florida. He returned to the United States after 10 years in Asia and Latin America and has dedicated much of his time to the issues of cancer control and access to medications in low- and middle-income countries. Dr. Lopes is the editor in chief of ASCO's Journal of Global Oncology, associate editor for the ASCO University Editorial Board, 2016-2017 chair of the International Clinical Trials Workshop Working Group, and global health track leader for the Cancer Education Committee, among other volunteer roles. Follow him on Twitter @GlopesMd.

Jul 11, 2016
Follow-on biologics are here to stay, and represent enormous potential for patients with cancer being treated in low- and middle-income countries.
May 23, 2016
This is the story of how, like Mr. Smith in Washington, the medical community in Brazil gathered to speak truth to power about the lack of evidence for phosphoethanolamine as a cancer treatment.
Apr 05, 2016
This is the story of how a populist Congress approved the medication that wasn't, and oncologists in the country are waiting to see if an enfeebled president will be able to veto the bill.
Feb 24, 2016
This is the story of how an eager chemistry professor and a well-intended but misguided federal judge transformed cancer care and drug development in Brazil into a convoluted soap opera.
Feb 03, 2016
The decision to scale up the provision of oral chemotherapy was a watershed event in the regulation of private health insurance in Brazil; however, prospects for expanded access to such medicines in the public health system are bleak in the short term.
Jan 21, 2016
Price discrimination is an inequitable-sounding, but important, concept of charging different prices for the same product or service in different markets or segments of a market, usually based on consumers’ ability to pay.

Pages